Common stock warrants issued January 19, 2016
Issued 2016
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
XGN$8.47+0.95%
Exagen Inc.
Sector: Services-Medical LaboratoriesIndustry: Medical - Diagnostics & ResearchCountry: USExchange: Nasdaq
Mkt Cap:$205.19M
Float & O/S:
Inst Own:
DilutionScan read 39 of EXAGEN INC.'s SEC filings and found 9 warrant series, 1 ATM program, 3 shelf registrations and 2 completed offerings on file for XGN. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
Signal8 Summary
XGN
Growing revenue, heavy cash burn
Snapshot
Exagen is a small-cap diagnostics company that is growing its top line but burning cash to do so. FY 2025 revenue reached $66.6M, up 19.7% from the prior year, with a healthy 58.3% gross margin. However, the company lost $20.0M in net income, driven largely by $46.6M in sales and general administrative expenses (70% of revenue). The business generated negative free cash flow of $14.3M last year.
What's Happening Right Now
- : A new systematic review published in Lupus Science & Medicine confirms the superior diagnostic accuracy of Exagen's AVISE Lupus algorithm.
- : The company filed to register over 1.1 million new shares for employee compensation plans, signaling potential future dilution.
- : Exagen reported record Q1 2026 revenue of $17.3M, beating estimates, driven by higher test volume and improved pricing.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Expired
Common stock warrants issued March 31, 2016
Issued 2016
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Common stock warrants issued April 1, 2016
Issued 2016
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Exchange Warrants (pre-funded, June 22, 2021)
Issued 2021
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2020
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2023
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your XGN trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
